Regresar

Therapeutic opportunities in adult patients with covid-19

Abstract:

Since the emergence of this new disease, different laboratories around the world have launched several studies in search of new techniques and forms. The objective is: To identify the different therapeutic opportunities used in adult patients with COVID-19. Methodology: It is based on an integrated bibliographic review of literature obtained from different important scientific databases such as Medline, Scielo, Bioscience, Intensive Care Medicine, Pubmed, Sciencedirect, Google Scholar, ELSEVIER and publications of international health entities such as WHO, PAHO and MOH. Results: articles referring to several therapeutic alternatives as treatments in COVID-19 were identified, filtered and analyzed, and the most used were antiviral, anti-inflammatory and immunomodulatory drugs. Conclusions: Several drugs have been proposed as therapeutic alternatives to combat this virus, after reviewing bibliographic sources the drugs that have resulted in a better reaction in patients are hydroxychloroquine, favipiravir and lopinavir/ritonavir.